Literature DB >> 24307596

Continuous vagal IONM prevents recurrent laryngeal nerve paralysis by revealing initial EMG changes of impending neuropraxic injury: a prospective, multicenter study.

Eimear Phelan1, Rick Schneider, Kerstin Lorenz, Henning Dralle, Dipti Kamani, Andre Potenza, Niranjan Sritharan, Jenifer Shin, Gregory W Randolph.   

Abstract

OBJECTIVES/HYPOTHESIS: Existing intraoperative neuromonitoring (IONM) formats stimulate the recurrent laryngeal nerve (RLN) intermittently, exposing it to risk for injury in between stimulations. We report electrophysiologic parameters of continuous vagal monitoring, utilizing a novel real-time IONM format, and relate these parameters to intraoperative surgical maneuvers that delineate nascent adverse but reversible electrophysiologic parameters to prevent nerve injury. These results are correlated with postoperative vocal cord functional outcome. STUDY
DESIGN: Prospective multicenter tertiary study.
METHOD: Evoked vagal nerve waveform amplitude and latency changes during 102 thyroidectomies were recorded. Adverse electrophysiologic response was categorized into 1-concordant amplitude reduction and latency increase events (combined events) and 2-loss of signal (LOS). Surgical maneuvers were modified when adverse electrophysiologic findings were noted. All patients underwent preoperative and postoperative laryngoscopy; intraoperative electrophysiologic findings were correlated with postoperative laryngeal function.
RESULTS: Continuous vagal monitoring did not result in stimulation-evoked nerve injury or intraoperative adverse cardiac, pulmonary, or gastrointestinal effects. Both intraoperative combined events and LOS were associated with development of vocal cord paralysis (VCP) (P = 0.001 and P >0.001 respectively). Combined events had a positive predictive value (PPV) of 33%, negative predictive value (NPV) of 97%, and were reversible in 73%. LOS had a PPV of 83%, NPV of 98%, and was reversible in only 17%. Milder combined events and isolated amplitude or latency changes were not associated with VCP.
CONCLUSIONS: Continuous vagal monitoring is safe and provides real-time RLN evaluation during surgical maneuvers. Combined events and LOS, both easily identifiable intraoperatively, are related to the development of VCP. A combined event represents a largely reversible electrophysiologic change when the associated surgical maneuver is aborted. If allowed to continue, it can advance to LOS (which typically is significantly less reversible) and to postoperative VCP. Continuous vagal monitoring has utility in identifying real-time adverse concordant amplitude and latency changes (combined events), which can prompt modification of the associated surgical maneuver and may prevent RLN paralysis during thyroidectomy. LEVEL OF EVIDENCE: 4.
© 2014 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  CIONM; Continuous vagal monitoring; IONM; adverse EMG changes; amplitude and latency changes; combined events; neuromonitoring; recurrent laryngeal nerve injury; recurrent laryngeal nerve paralysis; thyroid surgery; vagal electrodes; vocal cord paralysis

Mesh:

Year:  2014        PMID: 24307596     DOI: 10.1002/lary.24550

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  50 in total

Review 1.  Electrophysiological neural monitoring of the laryngeal nerves in thyroid surgery: review of the current literature.

Authors:  Ahmed Deniwar; Emad Kandil; Gregory Randolph
Journal:  Gland Surg       Date:  2015-10

2.  Severity of Recurrent Laryngeal Nerve Injuries in Thyroid Surgery.

Authors:  Gianlorenzo Dionigi; Che-Wei Wu; Hoon Yub Kim; Stefano Rausei; Luigi Boni; Feng-Yu Chiang
Journal:  World J Surg       Date:  2016-06       Impact factor: 3.352

3.  Continuous Vagal Nerve Monitoring: Too Much of a Good Thing?

Authors:  David J Terris
Journal:  World J Surg       Date:  2016-03       Impact factor: 3.352

4.  Diagnostic, therapeutic and health-care management protocol in thyroid surgery: a position statement of the Italian Association of Endocrine Surgery Units (U.E.C. CLUB).

Authors:  L Rosato; C De Crea; R Bellantone; M L Brandi; G De Toma; S Filetti; P Miccoli; F Pacini; M R Pelizzo; A Pontecorvi; N Avenia; L De Pasquale; M G Chiofalo; A Gurrado; N Innaro; G La Valle; C P Lombardi; P L Marini; G Mondini; B Mullineris; L Pezzullo; M Raffaelli; M Testini; M De Palma
Journal:  J Endocrinol Invest       Date:  2016-04-08       Impact factor: 4.256

Review 5.  [Vocal cord paralysis after thyroid surgery : Current medicolegal aspects of intraoperative neuromonitoring].

Authors:  H Dralle; R Schneider; K Lorenz; N Thanh Phuong; C Sekulla; A Machens
Journal:  Chirurg       Date:  2015-07       Impact factor: 0.955

Review 6.  [Intraoperative avoidance and recognition of recurrent laryngeal nerve palsy in thyroid surgery].

Authors:  D Simon; M Boucher; P Schmidt-Wilcke
Journal:  Chirurg       Date:  2015-01       Impact factor: 0.955

Review 7.  Recovery of laryngeal function after intraoperative injury to the recurrent laryngeal nerve.

Authors:  Per Mattsson; Jonas Hydman; Mikael Svensson
Journal:  Gland Surg       Date:  2015-02

8.  Continuous intraoperative neural monitoring in thyroid surgery: a Mexican experience.

Authors:  Karla Verónica Chávez; Jackeline Ramírez; Juan Pablo Pantoja; Mauricio Sierra; David Velázquez-Fernández; Miguel F Herrera
Journal:  Updates Surg       Date:  2017-05-10

Review 9.  Intraoperative neural monitoring in thyroid surgery: lessons learned from animal studies.

Authors:  Che-Wei Wu; Gregory W Randolph; I-Cheng Lu; Pi-Ying Chang; Yi-Ting Chen; Pao-Chu Hun; Yi-Chu Lin; Gianlorenzo Dionigi; Feng-Yu Chiang
Journal:  Gland Surg       Date:  2016-10

Review 10.  Continuous intraoperative neural monitoring of the recurrent nerves in thyroid surgery: a quantum leap in technology.

Authors:  Rick Schneider; Gregory W Randolph; Marcin Barczynski; Gianlorenzo Dionigi; Che-Wei Wu; Feng-Yu Chiang; Andreas Machens; Dipti Kamani; Henning Dralle
Journal:  Gland Surg       Date:  2016-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.